| ORIGINAL ARTICLE |
|
| Year : 2015 | Volume
: 9
| Issue : 2 | Page : 51-55 |
|
|
Prevalence of gestational thyroid disorders in Zaria, north-western Nigeria
Jibril Mohammed El-Bashir1, Fayeofori Mpakabaori Abbiyesuku2, Ibrahim Sambo Aliyu1, Abdullahi Jibril Randawa3, Rabiu Adamu1, Sani Adamu4, Shehu Abubakar Akuyam1, Mohammed Manu1, Hafsat Maiwada Suleiman1, Rasheed Yusuf1, Amina Mohammed1
1 Department of Chemical Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
2 Department of Chemical Pathology, University College Hospital, Ibadan, Nigeria
3 Department of Obstetrics and Gynaecology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
4 Department of Chemical Pathology, Federal Teaching Hospital, Gombe, Gombe State, Nigeria
Correspondence Address:
Jibril Mohammed El-Bashir
Department of Chemical Pathology, Ahmadu Bello University Teaching Hospital, Zaria
Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0331-3131.177949
|
|
|
Background: Thyroid disorders are the second most common endocrine disorders found during pregnancy. Normal maternal thyroid function is critical for normal fetal development. Gestational thyroid dysfunctions complicate pregnancy with a significant increase in maternal and perinatal morbidity and mortality.
Objective: To assess the prevalence of thyroid disorders among pregnant women in Zaria.
Materials and Methods: Study population consisted of 300 apparently healthy pregnant women and 100 apparently healthy age-matched nonpregnant controls. Participants were not on any drug that can affect thyroid function. Serum thyroid hormones [thyroid stimulating hormone, free triiodothyronine (T 3 ), free thyroxine (T 4 ), and thyroid peroxidase (TPO) antibody] were assayed using enzyme-linked immunosorbent assay (ELISA). Data were analyzed using Epi Info 3.5.3 and P-values ≤0.05 were considered statistically significant.
Results: Ages (mean ± SD) were 25.41 ± 5.98 and 26.70 ± 5.83 years for pregnant women and controls, respectively. Parity mean ± SD were 2.32 ± 2.24 and 2.63 ± 2.75 for pregnant women and controls, respectively. The mean gestational age ± SD was 21.68 ± 10.38 weeks. Three percent (3%) were hypothyroid, while 2.3% were hyperthyroid. Nine percent (9%) were TPO antibody positive.
Conclusion: Prevalence of thyroid disorders among pregnant women in Zaria was high therefore routine screening of all pregnant women for thyroid disorders during antenatal care visits may be of benefit. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
